Altimmune, Inc. vs GENFIT
Altimmune, Inc.
Late clinical-stage biotech working to improve the lives of those living with serious liver diseases
87 employees · est. 1997 · Gaithersburg, United States
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs
201 employees · est. 1999 · Loos, France
Altimmune, Inc. is the older company (1997 vs 1999); GENFIT is the larger of the two.
Side-by-Side Comparison
| Metric | Altimmune, Inc. | GENFIT |
|---|---|---|
| Founded | ||
| Founded | 1997 older | 1999 |
| Headquarters | ||
| Headquarters | Gaithersburg, United States | Loos, France |
| Employees | ||
| Employees | 87 | 201 larger |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | IPO | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $276.40M | $252.80M |
| Funding Rounds | ||
| Funding Rounds | 8 | 9 |
| Services | ||
| Services | development of peptide-based therapeutics, clinical stage research, drug development for liver diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | patients with metabolic dysfunction-associated steatohepatitis, patients with alcohol use disorder, patients with alcohol-associated liver disease, healthcare providers, biopharmaceutical investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalsLiver DiseasesClinical-StageMASH TherapyAUD TreatmentALD Therapy +7 | BiopharmaceuticalLiver DiseasesMetabolic DisordersDrug DiscoveryDrug DevelopmentClinical Trials +9 |
| Website | ||
| Website | altimmune.com | genfit.com |
About Altimmune, Inc.
Altimmune, Inc., founded in 1997, is a promising player in the biopharmaceutical sector, carving a niche in the treatment of liver-related diseases. Describing themselves as a "Late clinical-stage biotech working to improve the lives of those living with serious liver diseases," they focus on develo...
About GENFIT
GENFIT is a late-stage biopharmaceutical company with a focus on improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. With a history spanning over two decades, the company has shown prowess in developing high-potential assets, exemplified by...
Also comparing in this category
Comparing more than these two?
Get Altimmune, Inc., GENFIT and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Altimmune, Inc. compare?
A PDF of Altimmune, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Altimmune, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Altimmune, Inc. on 9 Jun 2026, and GENFIT on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
